Elevated level of cholesterol is a risk factor for the development of cardiovascular disease. Community pharmacies are considered as ideal settings to provide screening services for chronic medical conditions. An adequate knowledge and a positive attitude towards cholesterol screening would increase pharmacist's involvement in cholesterol lowering interventions and referrals. The objective of this study was to assess community pharmacists' knowledge, attitude and resource availability in relation to cholesterol screening in Delta State, Nigeria. A 33 item pre tested self-administered questionnaire with a Cronbach's alpha value of 0.628 was distributed to all 160 community pharmacists in Delta State. The questionnaire items assessed knowledge, attitude and available resources in relation to cholesterol screening. Categorical data was expressed as frequency and percentages. Chi-square test was performed to explore relationship between demographic variables and pharmacist's knowledge. A p-value of less than 0.05 was considered statistically significant. More than half (64.7%) of community pharmacist were knowledgeable in relation to cholesterol and its influence on cardiovascular diseases. Cholesterol screening services were provided by only 11.3% community pharmacies in Delta State. Majority (82%) were willing to be trained in the use of cholesterol meter. Nearly half, 42.9% had a negative attitude towards cholesterol screening. Pharmacist's knowledge about cholesterol and its influence in cardiovascular diseases was satisfactory. However, attitude towards cholesterol screening was largely negative and provision of such services was very low.
INTRODUCTION
Cardiovascular diseases (CVD) have continued to exact a heavy toll on people in developing and developed countries of the world with devastating impact on quality of life (Go et al., 2014; WHO, 2014; Mozaffarian et al., 2015) . Risk factors for development of CVD include high blood pressure, diabetes mellitus, smoking, and elevated *Corresponding author. E-mail: a_udave77@yahoo.com.
Author(s) agree that this article remain permanently open access under the terms of the Creative Commons Attribution License 4.0 International License serum cholesterol which is considered an independent risk factor for CVD (Wadhera et al., 2016; WHO, 2015; Keys et al., 1984) . A positive relationship exists between total serum cholesterol levels, triglyceride levels, other arthrogenic particles and the development of CVD especially coronary heart disease (Stamler et al., 1986; Toth, 2005; Assmann et al., 1998; Austin et al., 1998) .
Though the benefits of lowering cholesterol levels on the prevention of future heart attack, stroke, and death, have been well established both in those at risk and in persons with established CVD (Almuti et al., 2005; MRC/BHF, 2002; Anderson et al., 2013) , there is still a huge treatment gap leaving out many persons who would have benefited from lipid lowering therapy (Hoerger et al., 1998; Bolli, 2014; Ahn et al., 2015) . Also, for many persons on treatment, adherence to therapy is often compromised by perceived adverse effects of medication, resulting in discontinuation (Bitton et al., 2013; Roebuck et al., 2011) . Community pharmacists are in an ideal position to support management of dyslipidemia and reduce risks associated with CVD, because they are highly accessible and are often the first point of entry into the health care system (Joyce et al., 2007) . Pharmacists could assist by engaging in screening for dyslipidemia, promoting awareness and lifestyle interventions, and increasing adherence through assessment and resolution of drug therapy problems associated with use of lipid lowering medications.
A good knowledge of cholesterol and its influence on cardiovascular diseases, as well as a positive attitude towards cholesterol screening could increase impact of community pharmacists in reducing cardiovascular disease burden through cholesterol lowering interventions. The objectives of this study were too assess the knowledge of community pharmacists in relation to cholesterol and its influence on cardiovascular diseases, evaluate attitude of community pharmacists towards cholesterol screening and to determine resources available in community pharmacies for cholesterol screening.
MATERIALS AND METHODS

Study design
A cross sectional survey design was used for this study. A pretested 33 item questionnaire with Cronbach's alpha value of 0.628 was distributed to the resident pharmacists at the various community pharmacies in Delta State.
Setting
This research was carried out in registered community pharmacies located in Delta State, Nigeria. Delta State is an oil rich state situated in the Niger Delta region of the country. A teaching hospital, several general hospitals and a host of private medical facilities offer health care services in the state. Laboratory services are provided by public and private laboratory facilities in the state.
Population/sample size
The population consisted of all community pharmacies in the state. The total number of registered community pharmacists in the state was 160. In view of the small population size, a census of all community pharmacies in the state was done.
Data collection and presentation
A pretested self-completion questionnaire was distributed to the pharmacists in charge of all community pharmacies in the state. The questionnaire was pretested in a sample of 25 community pharmacists in Asaba, the state capital city. The questionnaire consisted of 33 questions divided into four sections. Section A addressed pharmacist demographics. Section B contained questions assessing pharmacist's knowledge, while Section C addressed pharmacist's attitude towards cholesterol screening. Section D consisted of questions relating to resource availability for cholesterol screening in community pharmacies. Institutional permit was obtained for the study.
Data analysis
Data collected were entered into Microsoft Excel spread sheet and crosschecked for errors and missing data. Then, they were finally exported into the Statistical Package for Social Sciences (SPSS) software. Responses to the 20 knowledge questions were expressed as frequency and percentages. Pharmacists attitude was measured on a 5 point Likert scale ranging from 1 (strongly agree to 5 (strongly disagree) with an assumed midpoint of 3. Rated scores were treated as interval data suitable for quantitative analysis. Chi-square test was performed to explore relationship between demographic variables and pharmacist's knowledge. A pvalue of less than 0.05 was considered statistically significant.
RESULTS
Demographic characteristics of pharmacists
A total of 160 questionnaires were distributed but 150 were retrieved thus giving a response rate of 93.75%. Cronbach's alpha value for the questionnaire showed modest level of internal consistency (0.628). There were more females (84, 56%) than males (66, 44%). The predominant age group was 31 to 40 years. Nearly half of the pharmacists have been in the practice for 5 to 10 years (42%) and most of them had no additional qualifications (60%) ( Table 1) .
Knowledge of cardiovascular disease
Knowledge about cholesterol and its influence in cardiovascular diseases was satisfactory as more than half (64.7%) of the respondents answered all knowledge questions correctly. However, scores were very low on questionnaire items relating to treatment targets for Table 2) .
Proportion of pharmacists that answered knowledge questions correctly
Age, practice experience and additional qualifications were significantly associated with pharmacist's knowledge of cholesterol (Table 3) .
Attitude to cholesterol screening
The overall percentage positive response to questions reflecting a negative attitude to cholesterol screening was 42.9% indicating that nearly half of pharmacists had a negative attitude towards cholesterol screening. Affordability of the cholesterol screening equipment was not a major factor influencing this negative attitude as only 5.3% strongly agreed or agreed with the statement that they could not afford cholesterol meters. More than half; 63.3% strongly agreed or agreed that cholesterol screening was not feasible in the pharmacy and that it should be left to laboratory scientists (63.9%). Details of pharmacist attitude with respect to cholesterol screening are shown in Table 4 .
Resources for cholesterol screening
More than half of pharmacists surveyed (62%) were involved in blood pressure screening. Only 17 (11.3%) had cholesterol meters in the pharmacy and cholesterol screening was done by a very small percentage of pharmacists (9.3%). Majority (82%) of the pharmacists expressed a willingness to be trained in the use of cholesterol metre (Table 5) .
DISCUSSION
The study population represented a wide variety of pharmacists' cutting-across different age, gender, and experience in community pharmacy practice. There was predominance of females in the study population. This is in line with a similar study carried out in Great Britain in 2005 where it was observed that over 54.7% of practicing pharmacists were of the female gender (Hassell and Eden, 2006) . More than half of community pharmacists were knowledgeable in relation to cholesterol and its influence Strongly agree (SA)=1; Agree (A)=2; 3=undecided (U)=3; disagree (D)=4; strongly disagree (SD)=5. Scale is 1-5; midpoint =3. Positive (%)=strongly agree plus agree. on cardiovascular diseases. Pharmacists' knowledge regarding the sources of cholesterol, forms of cholesterol, diet, cholesterol lowering therapies was quite impressive, with majority of the pharmacists selecting a statin as the first line agent for lowering high blood cholesterol line with the National Cholesterol Education Program guidelines (NCEP, 2002) . However, pharmacists exhibited knowledge deficits in the following areas; treatment benchmark for LDL, treatment goal for total cholesterol, and treatment goal for LDL. This finding is similar to that of an Australian study (Lee et al., 2013) . Also, knowledge of most common side effects associated with the use of statins was poor as more than half of the pharmacists chose gastric distress as a major side effect of statin therapy. Improved knowledge in these areas may facilitate improved case detection rates in the community through opportunistically testing selected patients presenting for a statin prescription. These findings might indicate a need for additional training and enlightenment of community pharmacists in Delta State.
Nearly half of the community pharmacists had a negative attitude towards cholesterol screening. This finding is in contrast to results of a similar study involving 200 pharmacists in Iran which showed that majority (70.4%) of practicing pharmacists had an overall positive attitude to providing cholesterol screening services (Jahangard-Rafsanjani et al., 2014) . This may be due to the poor resource availability profile of pharmacists surveyed in this study. Other barriers to cholesterol screening services observed from the Iranian study include a lack of regulatory policy and compensation mechanism, limited physical space in pharmacy, and time limitation. Even though there was a low level of involvement of community pharmacists in cholesterol screening in Delta State, practice experience and additional qualifications were significantly associated with higher knowledge and increased involvement in cholesterol screening. This finding is in contrast to other studies that show an inverse relationship between pharmacists practice experience and knowledge (Ibrahim and Hussein, 2017; Khan and Azha, 2017) .
The significant association between additional qualification and knowledge agrees with the findings of an Indian study that showed that pharmacists with additional qualifications were significantly more knowledgeable than those with basic pharmacy degree (Ahmad et al., 2013) . The most common service rendered was blood pressure assessment. The frequency of blood glucose, weight assessment and cholesterol screening performed in the various pharmacy outlets were also very low. The aforementioned Iranian study showed that although two-third of the participants believed that well-trained pharmacists can effectively deliver such services in community pharmacies, cholesterol screening services were rarely provided in Iranian community pharmacies. In contrast to these findings, pharmacists in developed countries have been involved in cholesterol screening and cardiovascular risk assessment for decades (Blenkinsopp et al., 2003; Bluml et al., 2000) . That 
Conclusion
Pharmacist's knowledge about cholesterol and its influence in cardiovascular diseases was satisfactory. Pharmacists' attitude towards providing cholesterol screening services in community pharmacies in Delta State was largely negative and resource availability was poor. However, majority of the pharmacists surveyed expressed willingness to be trained in the use of cholesterol meter.
RECOMMENDATION
Community pharmacy-based cholesterol screening training model should be developed in order to improve participation, output and impact of pharmacists in disease screening activities and to increase opportunistic high cholesterol detection rates in the general population.
